Search Results 2071-2080 of 19236 for Enzyme

1. Publications - Tyler S. Oesterle, M.D., M.P.H. - Mayo Clinic

   Plasma TREM2 Levels, Alcohol Consumption, and Liver Enzymes in Patients with Alcohol use Disorder: A Sex-Dependent Relationship Involving MS4A6A Genetic ...

2. Study finds micronutrient deficiencies common at time of celiac disease diagnosis - Mayo Clinic News Network

   — Micronutrient deficiencies, including vitamins B12 and D, as well as folate, iron, zinc and copper, are common in adults at the time of diagnosis with celiac ...

3. Chemotherapy-induced cognitive impairment: A potential preventive strategy - Mayo Clinic

   Declines in cellular NAD+ levels and its rate-limiting enzyme, nicotinamide phosphoribosyltransferase (known as NAMPT), play a pathogenic role in age-related ...

4. Mayo Clinic News Network Title: Balloon Lightens Weight Loss Burden / Date: June 2016 Intro

   Mark Harlan speaking. “I had some fatty liver problems; they're all gone. Liver enzymes are in shape.” Dr. Andres Acosta speaking. “But, then, we need to think ...

5. A Study to Evaluate Food on Gastrointestinal Toxicity and The Effect of Selumetinib in Adolescents with Neurofibromatosis Type 1 - Mayo Clinic

   Receiving herbal supplements or medications known to be strong or moderate inhibitors or inducers of the CYP2C19 and CYP3A4 enzymes unless such products can ...

6. Clinical trials - Oncology (Medical)

   ... enzymes needed for cell growth. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of ...

7. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

   Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with obinutuzumab, may induce changes in ...

8. Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer - Mayo Clinic

   * Participants receiving any medications or substances that are strong or moderate inhibitors or inducers of CYP450 enzyme(s) are ineligible. This also ...

9. Clinical trials - Oncology (Medical)

   Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy With or Without Immunotherapy for ...

10. Clinical trials - Oncology (Medical)

    Olaparib and cediranib maleate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib, cediranib maleate, and ...